- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Beremagene geperpavec is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- D03AX16 Beremagene geperpavec · Cicatrizant, subgroup D03AX
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
- Identifiers
- UNII AQN7K24KQUQ119475442
All presentations
No presentations of Beremagene geperpavec are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Beremagene geperpavec available for export from India?
No presentation of Beremagene geperpavec is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Beremagene geperpavec authorised in the European Union?
Yes. Beremagene geperpavec has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Beremagene geperpavec need cold chain shipping?
No listed presentation of Beremagene geperpavec is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Beremagene geperpavec in?
Beremagene geperpavec is classified under ATC code D03AX16 (Beremagene geperpavec).
References
- Vyjuvek: European public assessment report (EPAR). European Medicines Agency. Retrieved 8 June 2026
Request Beremagene geperpavec for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.